ArticleCancer biology & therapy2012

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

Jill P Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.